Activated Interferon-γ-Positive T Lymphocytes and Cytokine Signatures in Patients With Postinfectious Cough

Abstract

Postinfectious subacute cough (PISC) and postinfectious chronic cough (PICC) are triggered by respiratory infections, which induce adaptive immunity. The expression of T-lymphocyte subsets and cytokine signatures remains elusive in these patients. Here, we recruited 40 healthy controls, 64 PICC patients, 65 PISC patients, and 20 recovered individuals with postinfectious subacute cough (R-PISC). As cough and airway inflammation resolved in R-PISC subjects, sputum lymphocytes dropped substantially. Both PICC and PISC patients had an increase in blood activated interferon-γ (IFN-γ)⁺ T-lymphocytes, which were decreased in R-PISC subjects. Elevated cough sensitivity, higher proportions of activated IFN-γ⁺ T-lymphocytes, and CD8⁺/CD4⁺ T-lymphocyte ratios, as well as elevated concentrations of uric acid, IFN-γ, tumor necrosis factor-α (TNF-α), IFN-α, IFN-β, and interleukin-10 in sputa, were observed in PICC and PISC patients but normalized in R-PISC subjects. Correlation analyses and logistic regression models identified activated IFN-γ⁺ T-lymphocytes and these cytokines in sputa as biomarkers for predicting cough risk. PICC patients exhibited greater cough severity, elevated activated IFN-γ⁺ T-lymphocytes, and TNF-α concentrations in sputa compared to PISC patients. Overall, postinfectious cough patients exhibit airway inflammatory signatures characterized by activated IFN-γ⁺ T-lymphocytes and elevated levels of IFN-γ, TNF-α, IFN-α, IFN-β, and interleukin-10, which are valuable for effective treatment options.

Keywords

airway inflammation / cytokines / immune responses / postinfectious cough / T lymphocytes

References

[1] L Lin, ZF Yang, YQ Zhan, et al., “The Duration of Cough in Patients With H1n1 Influenza,” Clinical Respiratory Journal 11, no. 6 (2017): 733-738.

[2] RS Irwin, CL French, AB Chang, et al., “Classification of Cough as a Symptom in Adults and Management Algorithms: Chest Guideline and Expert Panel Report,” Chest 153, no. 1 (2018): 196-209.

[3] SS Braman, “Postinfectious Cough: Accp Evidence-Based Clinical Practice Guidelines,” Chest 129, Suppl no. 1 (2006): 138S-146S.

[4] RA Strauss, “Treatment of Postviral Nonasthmatic Cough With Corticosteroids,” Journal of Allergy and Clinical Immunology: In Practice 1, no. 4 (2013): 404-406.

[5] JY Ham, KE Song, NY. Lee, “Incidence and Distribution of Respiratory Microorganisms Causing Acute Respiratory Infections at the University Hospital of Korea,” Clinical Laboratory 66, no. 12 (2020).

[6] Y Chen, X Zhang, X Zeng, et al., “Prevalence and Risk Factors for Postinfectious Cough in Discharged Patients With Coronavirus Disease 2019 (Covid-19),” Journal of Thoracic Disease 14, no. 6 (2022): 2079-2088.

[7] AC Kalil, PG. Thomas, “Influenza Virus-Related Critical Illness: Pathophysiology and Epidemiology,” Critical Care (London, England) 23, no. 1 (2019): 258.

[8] KK To, KH Chan, IW Li, et al., “Viral Load in Patients Infected With Pandemic H1n1 2009 Influenza a Virus,” Journal of Medical Virology 82, no. 1 (2010): 1-7.

[9] L Zou, F Ruan, M Huang, et al., “Sars-Cov-2 Viral Load in Upper Respiratory Specimens of Infected Patients,” New England Journal of Medicine 382, no. 12 (2020): 1177-9.

[10] K Liang, P Hui, S. Green, “Postinfectious Cough in Adults,” Cmaj 196, no. 5 (2024): E157.

[11] CV Ramana, MP DeBerge, A Kumar, et al., “Inflammatory Impact of IFN-Gamma in Cd8+ T Cell-Mediated Lung Injury Is Mediated by Both Stat1-Dependent and -Independent Pathways,” American Journal of Physiology. Lung Cellular and Molecular Physiology 308, no. 7 (2015): L650-7.

[12] Z Huang, KE Brodeur, L Chen, et al., “Type I Interferon Signature and Cycling Lymphocytes in Macrophage Activation Syndrome,” Journal of Clinical Investigation 133, no. 22 (2023): e165616.

[13] W Ding, R Li, T Song, et al., “Amg487 Alleviates Influenza a (H1n1) Virus-Induced Pulmonary Inflammation Through Decreasing IFN-Gamma-Producing Lymphocytes and IFN-Gamma Concentrations,” British Journal of Pharmacology 181, no. 13 (2024): 2053-2069.

[14] N Bryant, LM Muehling, K Wavell, et al., “Rhinovirus as a Driver of Airway T Cell Dynamics in Children With Treatment-Refractory Recurrent Wheeze,” JCI Insight 10, no. 9 (2025): e189480.

[15] ME Schmidt, SM. Varga, “Cytokines and Cd8 T Cell Immunity During Respiratory Syncytial Virus Infection,” Cytokine 133 (2020): 154481.

[16] T Menon, PT Illing, P Chaurasia, et al., “Cd8(+) T-Cell Responses Towards Conserved Influenza B Virus Epitopes Across Anatomical Sites and Age,” Nature Communications 15, no. 1 (2024): 3387.

[17] R Zheng, Y Li, D Chen, et al., “Changes of Host Immunity Mediated by IFN-Gamma(+) Cd8(+) T Cells in Children With Adenovirus Pneumonia in Different Severity of Illness,” Viruses 13, no. 12 (2021): 2384.

[18] BA Krishna, EY Lim, M Metaxaki, et al., “Spontaneous, Persistent, T Cell-Dependent ifn-Gamma Release in Patients Who Progress to Long Covid,” Science Advances 10, no. 8 (2024): eadi9379.

[19] Z Deng, W Ding, F Li, et al., “Pulmonary IFN-Gamma Causes Lymphocytic Inflammation and Cough Hypersensitivity by Increasing the Number of IFN-Gamma-Secreting T Lymphocytes,” Allergy, Asthma & Immunology Research 14, no. 6 (2022): 653-73.

[20] I Raphael, S Nalawade, TN Eagar, TG. Forsthuber, “T Cell Subsets and Their Signature Cytokines in Autoimmune and Inflammatory Diseases,” Cytokine 74, no. 1 (2015): 5-17.

[21] C. Dong, “Cytokine Regulation and Function in T Cells,” Annual Review of Immunology 39 (2021): 51-76.

[22] H Liu, Q Zhao, L Tan, et al., “Neutralizing Il-8 Potentiates Immune Checkpoint Blockade Efficacy for Glioma,” Cancer Cell 41, no. 4 (2023): 693-710. e8.

[23] M Saraiva, P Vieira, A O'Garra, “Biology and Therapeutic Potential of Interleukin-10,” Journal of Experimental Medicine 217, no. 1 (2020): e20190418.

[24] Z Deng, W Zhou, J Sun, et al., “IFN-Gamma Enhances the Cough Reflex Sensitivity via Calcium Influx in Vagal Sensory Neurons,” American Journal of Respiratory and Critical Care Medicine 198, no. 7 (2018): 868-79.

[25] MJ Patil, F Ru, H Sun, et al., “Acute Activation of Bronchopulmonary Vagal Nociceptors by Type I Interferons,” Journal of Physiology 598, no. 23 (2020): 5541-54.

[26] KF Naqvi, SB Mazzone, MU. Shiloh, “Infectious and Inflammatory Pathways to Cough,” Annual Review of Physiology 85 (2023): 71-91.

[27] M Liu, S Guo, JM Hibbert, et al., “Cxcl10/Ip-10 in Infectious Diseases Pathogenesis and Potential Therapeutic Implications,” Cytokine & Growth Factor Reviews 22, no. 3 (2011): 121-30.

[28] J Du, L Wei, G Li, et al., “Persistent High Percentage of Hla-Dr(+)Cd38(High) Cd8(+) T Cells Associated With Immune Disorder and Disease Severity of Covid-19,” Frontiers in Immunology 12 (2021): 735125.

[29] J Yunis, KR Short, D. Yu, “Severe Respiratory Viral Infections: T-Cell Functions Diverging From Immunity to Inflammation,” Trends in Microbiology 31, no. 6 (2023): 644-56.

[30] TS Kim, EC. Shin, “The Activation of Bystander Cd8(+) T Cells and Their Roles in Viral Infection,” Experimental & Molecular Medicine 51, no. 12 (2019): 1-9.

[31] CA Anderson, P Patel, JM Viney, et al., “A Degradatory Fate for Ccr4 Suggests a Primary Role in Th2 Inflammation,” Journal of Leukocyte Biology 107, no. 3 (2020): 455-66.

[32] PA Wark, SL Johnston, I Moric, et al., “Neutrophil Degranulation and Cell Lysis Is Associated With Clinical Severity in Virus-Induced Asthma,” European Respiratory Journal 19, no. 1 (2002): 68-75.

[33] SF Seys, V Hox, L Van Gerven, et al., “Damage-Associated Molecular Pattern and Innate Cytokine Release in the Airways of Competitive Swimmers,” Allergy 70, no. 2 (2015): 187-94.

[34] Y Colak, S Afzal, P Lange, et al., “Role and Impact of Chronic Cough in Individuals With Asthma From the General Population,” Journal of Allergy and Clinical Immunology: In Practice 7, no. 6 (2019): 1783-92. e8.

[35] DKJ Pieren, NAM Smits, RJ Postel, et al., “Co-Expression of Tigit and Helios Marks Immunosenescent Cd8(+) T Cells During Aging,” Frontiers in Immunology 13 (2022): 833531.

[36] W Xue, J Ma, Y Li, C Xie, “Role of Cd(4) (+) T and Cd(8) (+) T Lymphocytes-Mediated Cellular Immunity in Pathogenesis of Chronic Obstructive Pulmonary Disease,” Journal of Immunology Research 2022 (2022): 1429213.

[37] QA Hamid, LA. Cameron, “Recruitment of T Cells to the Lung in Response to Antigen Challenge,” Journal of Allergy and Clinical Immunology 106, Suppl no. 5 (2000): S227-S234.

[38] W Ding, D Xu, F Li, et al., “Intrapulmonary IFN-Gamma Instillation Causes Chronic Lymphocytic Inflammation in the Spleen and Lung Through the Cxcr3 Pathway,” International Immunopharmacology 122 (2023): 110675.

[39] M Abdo, F Pedersen, AM Kirsten, et al., “Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma,” Journal of Allergy and Clinical Immunology: In Practice 10, no. 6 (2022): 1545-53. e2.

[40] P Maestrelli, M Saetta, A Di Stefano, et al., “Comparison of Leukocyte Counts in Sputum, Bronchial Biopsies, and Bronchoalveolar Lavage,” American Journal of Respiratory and Critical Care Medicine 152, no. 6 Pt 1 (1995): 1926-31.

[41] J Rojas-Quintero, X Wang, J Tipper, et al., “Matrix Metalloproteinase-9 Deficiency Protects Mice From Severe Influenza a Viral Infection,” JCI Insight 3, no. 24 (2018): e99022.

[42] J Sun, C Zhan, Z Deng, et al., “Expression of Interferon-Gamma and Its Effect on Cough Hypersensitivity in Chronic Refractory Cough Patients,” Thorax 77, no. 6 (2022): 621-4.

[43] SS Birring, CE Brightling, FA Symon, et al., “Idiopathic Chronic Cough: Association With Organ Specific Autoimmune Disease and Bronchoalveolar Lymphocytosis,” Thorax 58, no. 12 (2003): 1066-70.

[44] D Hartl, M Griese, T Nicolai, et al., “Pulmonary Chemokines and Their Receptors Differentiate Children With Asthma and Chronic Cough,” Journal of Allergy and Clinical Immunology 115, no. 4 (2005): 728-36.

[45] WJ Song, CKM Hui, JH Hull, et al., “Confronting Covid-19-Associated Cough and the Post-Covid Syndrome: Role of Viral Neurotropism, Neuroinflammation, and Neuroimmune Responses,” Lancet Respiratory Medicine 9, no. 5 (2021): 533-44.

[46] Y Vazquez, L Gonzalez, L Noguera, et al., “Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update,” Frontiers in Immunology 10 (2019): 1154.

[47] Y Chang, JS Kang, K Jung, et al., “Oasl1-Mediated Inhibition of Type I IFN Reduces Influenza A Infection-Induced Airway Inflammation by Regulating Ilc2s,” Allergy, Asthma & Immunology Research 14, no. 1 (2022): 99-116.

[48] S Mukhopadhyay, JR Hoidal, TK. Mukherjee, “Role of Tnfalpha in Pulmonary Pathophysiology,” Respiratory Research 7, no. 1 (2006): 125.

[49] A Jatakanon, UG Lalloo, S Lim, et al., “Increased Neutrophils and Cytokines, TNF-Alpha and Il-8, in Induced Sputum of Non-Asthmatic Patients With Chronic Dry Cough,” Thorax 54, no. 3 (1999): 234-7.

[50] K Lai, L Lin, B Liu, et al., “Eosinophilic Airway Inflammation Is Common in Subacute Cough Following Acute Upper Respiratory Tract Infection,” Respirology (Carlton, Vic.) 21, no. 4 (2016): 683-8.

[51] EC Hilton, PG Baverel, A Woodcock, et al., “Pharmacodynamic Modeling of Cough Responses to Capsaicin Inhalation Calls Into Question the Utility of the C5 End Point,” Journal of Allergy and Clinical Immunology 132, no. 4 (2013): 847-55. e1-5.

[52] PW West, A Kelsall, S Decalmer, et al., “PCR Based Bronchoscopic Detection of Common Respiratory Pathogens in Chronic Cough: A Case Control Study,” Cough 8, no. 1 (2012): 5.

[53] M Zhang, DL Sykes, K Brindle, et al., “Chronic Cough—The Limitation and Advances in Assessment Techniques,” Journal of Thoracic Disease 14, no. 12 (2022): 5097-119.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.